Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial
The good news is that these dysesthesia events were generally mild
7 Semaglutides role in the medical triad of diabetes, obesity, and cancer The prevalence of T2DM has increased significantly in the past decades
after getting FDA approval in 2022
Retatrutide should not be confused with anabolic steroids, which are completely different substances
Matthews DR, Paldnius PM, Proot P et al (2019) Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial